Abstract
Immunotherapy based on monocyte-derived dendritic cells (moDCs) has been explored for its potential to induce protective immunity and may act as an adjuvant to antiretroviral treatment in HIV infection. DCs interact directly with TCD4 and TCD8 lymphocytes, presenting antigens and initiating specific responses. However, the immune microenvironment is also composed of a complexity of cellul…